Authors | Number of patients | Male/female | Age (years) | Paprosky classification | Follow-up | mHHS of the last follow-up | Survivorship of the last follow-up | Complications |
---|---|---|---|---|---|---|---|---|
Webb et al. [7] | 20 | 9/11 | 67 | Type 3a (55%); type 3b (45%) | 28.8 months | 68.7 | No failure | Complication incidence (40%), dislocation (30%), delayed wound healing (15%) |
Loppini et al. [12] | 16 | 5/11 | 68 | Type 3a (44%); type 3b (56%) | 34 months | 77.2 | No failure | Complication incidence (18.8%), deep venous thrombosis (6.3%) |
Our current series | 18 | 8/10 | 68.3 | Type 3a (61.1%); type 3b (38.9%) | 61.0 months | 73.7 | No failure | Complication incidence (33.3%), dislocation (16.7%), delay wound healing (16.7%) |